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Focal dermal hypoplasia (FDH) is a rare syn- 
drome of severe developmental anomalies of 
the tissues and organs derived from ectoderm 
and mesoderm. Though data have suggested 
that FDH is an X-linked dominant trait associ- 
ated with male hemizygote lethality, a hypoth- 
esis supported by the observation of three un- 
related infants with FDH manifestations and 
de novo chromosome rearrangements involv- 
ing Xp22, observations of father-to-daughter 
transmission have suggested possible genetic 
heterogeneity and autosomal dominant in- 
heritance with sex limitation. We hypothesize 
that, if FDH is an X-linked disorder, cells ex- 
pressing an active disease locus might experi- 
ence a selective disadvantage resulting in a 
nonrandom pattern of X-inactivation in pa- 
tient tissue. To test this hypothesis, we studied 
one of the two previously described families 
demonstrating father-to-daughter inheri- 
tance of FDH. To determine if the affected 
daughter had a skewed pattern of X-inactiva- 
tion consistent with X-linked inheritance of 
FDH, somatic cell hybrids were constructed 
by fusing hypoxanthine phosphoribosyl 
transferase (HPRThdeficient rodent fibro- 
blasts with either patient dermal fibroblasts 
or peripheral white blood cells (WBCs); hy- 
brid clones retaining an active X chromosome 
were analyzed to determine the parental ori- 
gin of the active X chromosome. Analyses of 
resulting hybrid clones showed that while hy- 
brids constructed from skin fibroblasts con- 
tained an active X chromosome inherited 
from either of the patient’s parents, hybrids 
constructed from WBCs showed a skewed pat- 
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tern of X-inactivation; 11 of 11 hybrids con- 
tained an active maternal X chromosome 
(x2 = 12.2, P = .001). These findings indicated 
that, in this family, FDH was associated with a 
nonrandom pattern of X-inactivation consis- 
tent with X-linked inheritance, suggesting 
that the patient’s father was mosaic for a mu- 
tant FDH allele. 
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INTRODUCTION 
Several putatively X-linked diseases have been iden- 
tified which primarily affect women [Wettke-Schafer 
and Kantner, 19831. The reason for the observed excess 
of affected women has not been determined in most of 
these disorders. In some X-linked dominant disorders, 
the loss of hemizygous males has been well documented; 
for example, most males with severe ornithine transcar- 
bamylase deficiency die shortly after birth. In other 
disorders, it has been assumed that the death of hemi- 
zygous males occurs during gestation; the observed ex- 
cess of male spontaneous miscarriages in some kindreds 
segregating a putative X-linked dominant trait has sup- 
ported this presumption [Wettke-Schafer and Kantner, 
19831. However, the observations of similarly affected 
46,XY males and kindreds demonstrating father-to- 
daughter inheritance has suggested that some disorders 
may be phenotypically or genetically heterogeneous 
[Goltz et al., 19701. 
One disorder that is predominantly limited to women 
is focal dermal hypoplasia (FDH) or Goltz-Gorlin syn- 
drome (MIM 30560). This rare severe developmental 
disorder is characterized by focal areas of partial under- 
development or thinning of the dermis with consequent 
herniation of subcutaneous tissue [Goltz et al., 19621. 
Affected individuals have multiple congenital anoma- 
lies of tissues and organs derived from embryonic ecto- 
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derm and mesoderm including skeletal defects, eye 
anomalies such as colobomas and microphthalmia, and 
dermatologic abnormalities including linear hypo- or 
hyperpigmented macules, telangectasias, and papil- 
lomas [Freire-Maia and Pinheiro, 19841. Though 95% of 
FDH cases have been estimated to be nonfamilial, pre- 
sumably representing new mutations [F'ryns et al., 
19781, two alternative modes of inheritance have been 
postulated. It has been proposed that FDH is an 
X-linked dominant trait with male hemizygote lethality 
because most affected individuals are women, affected 
women experience an increased incidence of sponta- 
neous midgestational miscarriages of male fetuses 
[Goltz et al., 19621, and four pedigrees have demon- 
strated mother-to-daughter transmission [F'reeman, 
1955; Wodiansky, 1957; Ginsburg et al., 1970; Ruiz- 
Maldonado et al., 19741. The observation of three unre- 
lated females with manifestations suggestive of FDH 
and de nouo cytologic abnormalities involving region 
Xp22 [Al-Gazali et al., 1990; Temple et al., 1990al pro- 
vides additional support that FDH is X-linked. Alter- 
natively, an autosomal dominant sex-limited mode of 
inheritance was proposed [Goltz et al., 19701 based on 
the observations of multiple affected males and the ob- 
servation of two pedigrees with father-to-daughter in- 
heritance [Larregue et al., 1971; Burgdorf et al., 19811; 
however, these observations did not exclude the possi- 
bilitv that the affected males were mosaic for FDH [Tem- 
ple i t  al., 1990bl. 
Several X-linked disorders have been identified in 
which carrier women demonstrate a nonrandom pattern 
of X chromosome inactivation, presumably on the basis 
of a selective disadvantage to a subpopulation of cells 
with an expressed disease allele [Hall, 19881. We hy- 
pothesize that, if FDK is an X-linked disorder, cells 
expressing an active disease locus might experience a 
selective disadvantage resulting in a nonrandom pat- 
tern of X-inactivation in heterozygote tissue. To test this 
hypothesis, we studied one of the two previously de- 
scribed families with demonstrated father-to-daughter 
inheritance of FDH [Burgdorf et al., 19811. We now 
report our results which demonstrate that, in this fam- 
ily, FDH is associated with a nonrandom pattern of 
X-inactivation consistent with X-linked dominant in- 
heritance and paternal X chromosome mosaicism for 
FDH. 
MATERIALS AND METHODS 
Cell Lines 
Dermal explants were dissected from sterile skin bi- 
opsy samples and cultured in standard conditions. Per- 
ipheral white blood cells (WBCs) were biopsied by veni- 
puncture in heparinized tubes and separated from other 
cellular constituents by ficoll gradient centrifugation 
(LSM, Organon Teknika, Durham NC). Hypoxanthine 
phosphoribosyltransferase (HPRTI-deficient Chinese 
hamster fibroblasts, cell line RJK-88 [Fuscoe et al., 
19831, were fused with human peripheral WBCs, and 
HPRT-deficient murine fibroblasts, cell line M613 
[Kahan et al., 19741, were fused with human skin 
fibroblasts using polyethylene glycol as previously de- 
scribed [Gorski et al., 19891. Independent somatic cell 
hybrid clones, one per plate, were isolated and main- 
tained in DMEM media supplemented with 15% fetal 
bovine serum, penicillin-streptomycin (100 pg/ml), 4 
mM glutamine, HAT M hypoxanthine, M 
amethopterin, M thymidine), and 1 pM ouabain. 
DNA Isolation, Digestion, Blotting, 
and Hybridization 
DNA was isolated from cells by phenol/chloroform 
extraction of sodium dodecylsulfate (SDS) and pro- 
teinase K-treated cell lysates followed by ammonium 
acetate/ethanol precipitation [Hermann and Frischauf, 
19873. Restriction endonuclease digestions were per- 
formed by digesting 10 pg aliquots ofDNA to completion 
with a restriction enzyme per manufacturer's sugges- 
tions (Bethesda Research Laboratories, Bethesda, MD), 
as judged by minigel agarose electrophoresis. Digested 
DNA was fractionated by agarose electrophoresis, and 
depurinated DNA was transferred to Zeta-probe nylon 
membranes (BioRad, Richmond, CAI by alkaline trans- 
fer [Reed and Mann, 19851. Radiolabeled probes [Fein- 
berg and Vogelstein, 19831 were hybridized to the immo- 
bilized DNA at 65°C in 1.5xSSPE [Maniatis et al., 
19821, 0.5% nonfat dry milk, 1% SDS, and 100 yg/ml 
denatured salmon sperm DNA. Filters were washed at a 
final stringency of 0.1 x SSC [Maniatis et al., 19821,1% 
SDS at 65"C, and exposed to Kodak XAR-5 film with an 
intensifying screen for 3-72 hours. 
CLINICAL REPORTS 
Patient 1 
The proposita had multiple skeletal and dermatologic 
anomalies at birth. She was the 2,800 g product of a 
normal uneventful 40 week gestation to a 33-year-old 
woman who had one previous pregnancy resulting in a 
normal male infant. There was no known exposure to 
recognized teratogens. Congenital anomalies included a 
coloboma of the right iris and retina, a hypoplastic right 
nasal ala, perioral papillomas, right hemiatrophy, mul- 
tiple telangectasias, linear hyperpigmented macules, 
and linear streaks of dermal thinning with focal hernia- 
tions of subcutaneous tissue. Her right hand had a sin- 
gle mobile digit with a normal nail and a second small 
flaccid digit located radially. Both feet had deep clefts. 
Medial to the cleft, both feet had normal first digits; 
lateral to the clefts, the right foot had two nailless syn- 
dactylous digits and the left had two digits curved plan- 
tarward. Roentgenologic examinations showed a hypo- 
plastic right clavicle and osteopathia striata of the long 
bones; histologic examination of an atrophic macule 
showed normal stratified squamous epithelia with un- 
derlying adipose tissue and no discernible dermis [Burg- 
dorf et al., 19811. 
Her major motor development was normal, and at 12 
years, she was in an age-appropriate class. Her major 
cutaneous defects have required numerous skin-graft- 
ing procedures to repair superficial ulcerations over 
atrophic regions (Fig. 1). She had a surgical revision of 
her right lacrimal duct and recurrent bilateral otitis 
media resulting in bilateral conductive hearing loss and 
necessitating bilateral tympanostomies and surgical 0s- 
sicular chain repair. She had hypodontia; teeth were 
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Fig. 1. Patient 1 at age 20 months (A) and the dorsal surface of her legs at age 14 years (B). Focal 
hypotrichosis, right inferiornasal coloboma, labial papillomas, right upper limb ectrodactyly, linear der- 
mal atrophy in associated herniations of subcutaneous tissue, and linear hyperpigmented macules are 
shown. 
dysplastic with hypoplastic enamel and were delayed in 
eruption. She had an atraumatic fracture of the left tibia 
and a surgically reduced dislocated of the right radial 
head. 
Examination at 12 years showed all growth parame- 
ters below the 3rd centile with an occipitofrontal circum- 
ference ( O F 0  of 49 cm, height of 129.5 cm, and weight of 
23.6 kg. Additional findings included fine sparse hair 
with focal alopecia, right facial hemiatrophy, a highly 
arched palate, thoracolumbar scoliosis, and a narrow 
anterior-posterior thoracic diameter. Prometaphase 
chromosomal analysis showed a 46,XX chromosomal 
constitution. 
Patient 2 
The father of Patient 1, a 54-year-old man of normal 
proportions, had linear telangectasias, atrophic dermal 
depressions, and streaked hyperpigmented macules of 
his right chest, abdomen, and leg recognized during 
infancy. The herniation of subcutaneous tissue beneath 
the atrophic lesions of his right axilla and inguinal 
region developed later in life (Fig. 2). When he was 14, 
he had a traumatic fractured left femoral epiphysis and 
right humerus. Roentgenologic examination failed to 
show osteopathia striata of his long bones; histologic 
examination of an atrophic macule from the forearm 
showed an absence of papillary dermis with fatty re- 
placement [Burgdorf et al., 19811. Physical examina- 
tions failed to show other stigmata of FDH; hair and 
teeth were normal, and his nails showed mild linear 
streaking which, though consistent with FDH, may 
have been acquired. He had a normal prometaphase 
karyotype showing a 46,XY chromosomal constitution. 
Fig. 2. A right lateral view of Patient 2 at 54 years of age showing 
multiple linear irregularly depressed hyperpigmented macules (arrow- 
heads). 
RESULTS 
To distinguish the proposita’s paternally and mater- 
nally derived X chromosomes, DNAs isolated from pe- 
ripheral WBCs of the propositus (Patient l), her mother, 
and her father (Patient 2) were analyzed using oli- 
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bearing an active HGPRT gene were selected in HAT/ 
ouabain medium; to avoid clonal artifacts, only one hy- 
brid clone per plate was isolated. Fusion experiments 
using dermal fibroblasts yielded 22 separate hybrid 
clones. Most hybrids derived from dermal fibroblasts 
were unstable during passage; DNA was isolated from 
only seven of the resulting hybrids. Fusion experiments 
using venous WBCs yielded 21 individual hybrid clones. 
Most of the isolated hybrid clones were stable upon pas- 
sage; DNA was isolated from 14 different hybrids de- 
rived from venous WBCs. 
To determine the parental origin of the active X chro- 
mosome retained in each of the resultant hybrid clones, 
hybrid DNA was digested with MspI and hybridized 
with probe p58-1 to identify the DXS14 parental allele 
present (Fig. 3). Somatic cell hybrids derived from the 
proposita’s dermal fibroblasts contained both the mater- 
nal 2.4 kb allele (hybrids SA3 and SA4) and the paternal 
3.8 kb allele (hybrid SC5); these results were consistent 
with a random pattern of X-inactivation within the 
proposita’s fibroblasts. In contrast, in the somatic cell 
hybrids derived from the proposita’s WBCs, 11 of 11 
hybrids containing a single X chromosome contained 
the maternal 2.4 kb DXS14 allele (hybrids LD3, LD1, 
and LD5 contained both alleles). No hybrid clone con- 
tained the paternally derived DXS14 allele in isolation 
(Fig. 3). These results indicate a nonrandom pattern of 
X chromosome inactivation within the proposita’s 
WBCs or progenitors; the proposita’s maternal X chro- 
mosome was selectively active with an apparent defi- 
ciency in WBCs containing an active paternally derived 
X chromosome x2 = 12.2, P= .001, 1 DF). 
Attempts were made to  verify these observations by 
using cloned expressed DNA sequences as probes to 
identify the parental origin of the active X chromosome 
on the basis of differential methylation between an ac.. 
tive and inactive X chromosomal locus [Vogelstein et al., 
19851; unfortunately, neither the propositus nor her 
parents were informative (polymorphic) at X-chromo- 
soma1 loci (PGK or HGPRT) expressed in skin fibro- 
blasts [Fearon et al., 19871 (data not shown). 
DISCUSSION 
These analyses sought to answer two interrelated 
questions regarding the genetics and biology of FDH: 
1) Is FDH X-linked? and if so, 2) Are cells expressing a 
mutant FDH allele at a selective disadvantage? To 
address these questions, we used recombinant-DNA 
probes to study a family demonstrating father-to- 
daughter inheritance of FDH and analyzed somatic cell 
hybrids retaining an active X chromosome derived from 
the affected daughter. Though an apparently random 
pattern of X inactivation was observed in hybrids con- 
structed from dermal fibroblasts, preferential X inac- 
tivation of the paternal X chromosome was observed in 
hybrids derived from the proposita’s WBCs. Within this 
family, these findings are consistent with the hypoth- 
esis that FDH was inherited as an X-linked dominant 
trait and that the proposita’s father was mosaic for the 
mutant FDH gene. These findings suggest that the ex- 
pression of a mutant FDH allele was associated with a 
selective disadvantage in hematopoietic cells. The mild 
goradiolabeled DNA probes detecting X chromosome 
restriction fragment length polymorphisms. Analyses 
showed that both the propositus and her mother were 
heterozygous for the DXS14 MspI polymorphism de- 
tected with probe p58-1. DNA samples from the proposi- 
tus and her mother both contained the 3.8 and 2.4 kilo- 
base (kb) alleles; the DNA of the proposita’s father 
contained only the 3.8 kb allele, suggesting that the 
propositus inherited the 2.4 kb allele from her mother 
and the 3.8 kb from her father (Fig. 3). 
In order to determine the parental origin of the active 
X chromosome in cells isolated from the propositus (skin 
fibroblasts isolated from an atrophic lesion and periph- 
eral WBCs), somatic cell hybrids were constructed; biop- 
sied cells were fused with HGPRT-deficient rodent 
fibroblast cell lines using polyethylene glycol. Somatic 






Fig. 3. Autoradiogram of oligoradiolabeled probe p58-1 hybridized 
to filters containing 10 pg aliquots of MspI-digested DNA. DNAs were 
isolated from either peripheral venous blood samples (lanes 1-3; 
panels A and B) or somatic cell hybrids containing an X chromosome 
derived from Patient 1’s white blood cells (WBCs) (A) (LA2-LC2; lanes 
4-17) or skin fibroblasts (B) (SA3-SB3; lanes 4-10). Lane 1 contains 
DNA isolated from the father of Patient 1 (Patient 2); lanes 2, DNA 
isolated from Patient 1; lane 3, DNA isolated from the mother of Patient 
1.-Somatic cell hybrid cell lines derived from Patient 1’s fibroblasts 
contain both the maternal 2.4 kb (SA3, SA4) and paternal 3.8 kb (SC5) 
DXS14 alleles (B). All somatic cell hybrid cell lines derived from Pa- 
tient l’s WBCs contained the maternal 2.4 kb DXS14 allele; none ofthe 
14 isolated hybrid clones contained the paternal allele alone (A). 
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clinical manifestations of the affected father are consis- 
tent with mosaicism and are similar to the mild changes 
observed in males mosaic for other X-linked, hemizygote 
lethal disorders such as ornithine transcarbamylase de- 
ficiency [Maddalena et al., 1988; Legius et al., 19901 and 
X-linked agammaglobulinemia [Hendriks et al., 19891. 
Significant evidence indicates that, within the cells of 
an inner cell mass, X chromosome inactivation is ini- 
tially random, resulting in a mosaic population of cells; 
however, the proportion of the two mosaic populations 
may be subsequently skewed as a result of selection for 
alleles at loci influencing cell proliferation [Chapman, 
19861. In heterozygous women, the absence and pre- 
sumed loss of cells expressing a mutant X-chromosomal 
allele is well documented: B cells expressing a mutant 
allele are absent from carriers of X-linked agam- 
maglobulinemia [Conley et al., 1987; Fearon et al., 
19871, abnormal platelets are apparently lost from 
Wiskott-Aldrich carriers [Gealy et al., 1980; Prchal et 
al., 19801, dermal fibroblasts expressing a mutant in- 
continentia pigmenti allele are underrepresented 
[Wieacker et al., 1985; Migeon et al., 19891, and HPRT- 
deficient hematopoietic cells are absent in carriers of 
Lesch-Nyhan syndrome [Albertini and DeMars, 19741. 
In addition to providing a means to detect heterozygous 
women, these observations have assisted in providing 
information regarding the nature of the mutant gene 
product, the tissue in which the mutant gene is ex- 
pressed, and the developmental pattern of gene expres- 
sion and regulation. However, the demonstration of a 
nonrandom pattern of X-inactivation has not neces- 
sarily provided a plausible explanation for a disease 
phenotype. For example, among heterozygotes, while 
the demonstrated deficiency of B cells expressing a mu- 
tant agammaglobulinemia allele corresponds to the dis- 
ease phenotype of the affected hemizygote [Conley et al., 
1987; Fearon et al., 19871, the absence of hematopoietic 
cells expressing a mutant HPRT in Lesch-Nyhan car- 
riers does not correspond to the observed phenotype or 
play an obvious causative role in disease pathogenesis 
[Albertini and DeMars, 19741. 
Our analyses of a family demonstrating father-to- 
daughter transmission of FDH showed that, in somatic 
cell hybrids derived from the proposita’s WBCs, the 
maternally derived X chromosome was preferentially 
retained. These findings suggest that mutations at  the 
FDH locus may be detrimental to the proliferation of 
hematopoietic cells expressing the mutation, resulting 
in an underrepresentation of WBCs containing an active 
paternally derived X chromosome. Presumably, the loss 
of WBCs or precursors containing an active paternally 
derived X chromosome resulted from cell selection fol- 
lowing random X-inactivation. Because X chromosome 
inactivation patterns in females follow a binomial distri- 
bution curve [Fialkow, 19731, occasional normal females 
are expected to  have apparently nonrandom patterns of 
X-inactivation by chance alone. However, finding such 
a significantly skewed pattern of X-inactivation by 
chance, with selection against the paternally derived X 
chromosome in particular, is unlikely and provides new 
evidence that FDH is an X-linked disorder. 
The observation that WBCs, but not dermal fibro- 
blasts, demonstrate a nonrandom pattern of X-inactiva- 
tion suggests that in FDH, like HPRT deficiency [Alber- 
tini and DeMars, 19741, different cell types exhibit 
different tolerances toward a mutant disease locus. The 
apparent absence of nonrandom X-inactivation in der- 
mal fibroblasts suggests that, unlike incontinentia pig- 
menti in which observed dermatologic anomalies have 
been proposed to be secondary to the loss of cells expres- 
sing a mutant allele [Wieacker et al., 1985; Migeon et 
al., 19891, the dermatologic anomalies observed in FDH 
may be associated with cells expressing a mutant FDH 
allele. Resolution of this issue will require the analysis 
of additional FDH patients and multiple tissues from 
affected and nonaffected areas. 
We conclude that the nonrandom pattern of X-inac- 
tivation observed in the hematopoietic cells of the pro- 
positus of this family segregating FDH suggests, but 
does not prove, the existence of an X-linked locus for this 
disease. These analyses cannot rule out potential ge- 
netic heterogeneity, such as that recently demonstrated 
for Aicardi syndrome [Neidich et al., 19901; further 
analyses with additional patients will be required to 
verify these findings. The potential application of such 
analyses to carrier detection and prenatal diagnosis will 
be dependent upon verification. 
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